Abstract: An applicator includes a roller, a treatment composition component, a cutaneous measurement component, and a controller. The roller contacts a portion of skin at a contact location and subsequently a target location. The treatment composition component selectively deposits a composition on a roller surface at a deposition location that is on the roller surface a circumferential distance away from the contact location. The cutaneous measurement component generates one or more parameters associated with the target location on the portion of skin. The target location is a target distance from the contact location that is equal to or greater than the circumferential distance. The controller controls the treatment composition component to selectively deposit the treatment composition on the roller surface in response to the one or more parameters associated with the target location on the portion of skin generated by the cutaneous measurement component.

Abstract: Embodiments disclosed herein are directed to negative pressure treatment systems and wound dressing systems, apparatuses, and methods that may be used for the treatment of wounds. In particular, some embodiments are directed to improved wound dressings comprising an obscuring layer that may hide fluid contained therein. Some embodiments may further comprise one or more viewing windows disposed therethrough so as to enable monitoring or examination of fluids contained therein.

Abstract: An applicator for treating skin conditions includes at least one treatment composition component and a discontinuity identification component. The at least one treatment composition component is configured to selectively deposit a treatment composition at a deposit location on the portion of skin. The discontinuity identification component is operably coupled to an electromagnetic energy detector. The discontinuity identification component includes circuitry configured to monitor a level of the one or more parameters as the applicator traverses the portion of skin and to control the at least one treatment composition component to selectively deposit the treatment composition to the deposit location on the portion of skin based on one or more inputs indicative of a decrease in reflection of an electromagnetic energy interrogation stimulus from the portion of skin at the deposit location.

Abstract: A method for insertion, maintenance, and removal of urethral catheters in mammals including humans includes steps for preventing or reducing the incidence of catheter associated urinary tract infections. In addition to sterile procedures currently practiced or as may be practiced in the future in connection with catheter use, the method includes the steps of applying an antiseptic, zwitterionic, and acidic skincare solution capable of preserving the stratum corneum to the perineum, meatus, and contiguous mucosa surrounding the insertion site before insertion, after insertion, periodically during the period of indwelling, in connection with any incidence of incontinence, and, optionally, before and after removal of the catheter. Application of the solution optionally is continued after catheter removal on a periodic basis until the threat of an infection associated with catheter use has passed, typically at least about five (5) to seven (7) days and up to thirty (30) days.

Abstract: A wound covering assembly includes a wound covering membrane and a removable layer. The wound covering membrane can allow liquid or air to pass through the wound covering membrane from a wound site covered by the wound covering membrane to ambient and vice versa. The removable layer covers a portion of the wound covering membrane and is removable from the wound covering membrane when the wound covering membrane is affixed to skin around the wound site. The removable layer is configured and connected with the wound covering membrane such that air and liquid are inhibited from passing through the wound covering membrane and the removable layer when the wound covering membrane is affixed to skin surrounding the wound site and the removable layer is connected with the wound covering membrane. The wound covering assembly can be used with a pump assembly to provide negative pressure to the wound site.

Abstract: Device for packaging and dispensing drops of a substance for ophthalmic use, generally fluid, semi-fluid or in suspension, emulsion or oily solution, including a dispensing accessory with a first valve made of an elastomer material that allows the substance to pass through when the dispensing accessory is stressed, without allowing outside air to pass through in the opposite direction when the dispensing accessory is relaxed, characterized in that the first valve is covered by a layer of Parylene.

Abstract: An elastic composite (10, 110, 210, 310) can include a first layer (20, 120, 220, 320), a second layer (22, 122, 222, 322), and a third layer (24, 124, 224, 324). The third layer (24, 124, 224, 324) can be formed by at least one elastic material (32, 132, 232, 332) and can be coupled to the second layer (22, 122, 222, 322) when the elastic material (32, 132, 232, 332) is in an extended condition. The first layer (20, 120, 220, 320) can be coupled to the second layer (22, 122, 222, 322) near the first and second longitudinal edge (16, 18) but can be independent of the second layer (22, 122, 222, 322) therebetween such that the first layer (20, 120, 220, 320) forms gathers (36, 136, 236, 336) when the elastic composite (10, 110, 210, 310) is in a retracted condition.

Abstract: A makeup application component includes a three-dimensional mask, a transfer layer, and a pigment layer. A surface curve of a first surface of the three-dimensional mask is corresponding to a surface curve of a face of a user. The transfer layer covers the first surface of the three-dimensional mask. The transfer layer is provided with a first surface and a second surface that are opposite each other. The first surface of the transfer layer clings to the first surface of the three-dimensional mask, and the pigment layer is attached to the second surface of the transfer layer.

Abstract: An applicator includes a discontinuity identification component and at least one treatment composition component. The discontinuity identification component is operably coupled to an electromagnetic energy interrogation component and the discontinuity identification component is configured to determine a treatment status based on an interrogation response to an electromagnetic energy stimulus indicative of an absorption difference of greater than a target amount. The at least one treatment composition component is operably coupled to the discontinuity component and the at least one treatment composition component is configured to selectively deposit a treatment composition on the portion of skin responsive to one or more inputs from the discontinuity component indicative of a target treatment status.

Abstract: A dispenser for the delivery of a droplet of a liquid comprises a housing which defines an outlet orifice, a tip seal, biased against the housing to seal the outlet orifice, and a dosing pump for pumping a liquid to the outlet nozzle. The dispenser further comprises an actuation pump configured to provide a hydraulic opening force to the tip seal for opening of the outlet orifice. Preferably the actuation pump is configured to operate at a higher pressure than the dosing pump.

Abstract: A system and method of treating and protecting an injured claw of an animal. A claw cap is provided. The claw cap is an elastomeric cap that defines an interior compartment. A medicated compound may be provided within the interior compartment of the claw cap. The injured claw is advanced into the claw cap through the open end of the claw cap. The injured claw is exposed to the medicated compound within the interior compartment of the claw cap. The claw cap then engages the exterior of the injured claw with a friction fit. The claw cap remains on the injured claw as the animal resumes normal activities. The claw cap is removed once the medication has affected a significant degree of healing.

Abstract: The illustrative embodiments described herein are directed to a system and method for administering reduced pressure at a tissue site. The apparatus includes a reduced pressure source. The reduced pressure source generates a reduced pressure. The apparatus includes a tube having a plurality of lumens. The plurality of lumens includes at least one collection lumen. The reduced pressure source applies the reduced pressure to the tissue site through the plurality of lumens such that the at least one collection lumen receives fluid from the tissue site. The at least one collection lumen stores the fluid received from the tissue site.

Abstract: A system and method for providing fluid to a tissue site is described. The method fluidly couples an instillation therapy system to the tissue site and monitors a pressure supplied to the tissue site by a reduced-pressure source with the instillation therapy system for a time period. The method provides fluid to the tissue site with the instillation therapy system in response to the pressure at the tissue site during the time period. The system includes a pressure sensor fluidly coupled to the tissue site to measure a pressure proximate the tissue site. A valve and a flow meter are fluidly between a fluid reservoir and the tissue site. A controller is communicatively coupled to the pressure sensor and the valve and configured to monitor the pressure at the tissue site and a volume of fluid flow to the tissue and, in response, operate the valve.

Abstract: This absorbent article has sufficient pliability even when an absorbent body is bonded to a transport material, a wrap material, etc., and is pleasant to wear. In this absorbent article (1), an absorbent body (4) includes at least a hydrophilic fiber-containing hydrophilic fiber layer (5) having multiple non-through slits (8), and in the surface opposite of the surface having the slits (8), the hydrophilic fiber layer (5) has multiple recesses (9) in positions corresponding to the multiple non-through slits (8) in the thickness direction of the absorbent article (1).

Abstract: This relates to a wound therapy device, including an outer part and an inner part facing surface provided with an inner part facing opening, and a first connection channel to establish fluid communication between the inner part facing opening and a connector opening adapted to be connected to an external device. The wound therapy device can also be a part of a wound therapy arrangement, which can further include, a wound filler, an external device, a wound cover film, and tubing connections. Methods of using the wound therapy arrangement are also disclosed.